Çoklu Organ Destek Tedavisi

Boyle A, Ascheim D, Russo M, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant 2011; 30:402-7.

Fernández-Mondéjar E, Fuset-Cabanes MP, Grau-Carmona T, et al. The use of ECMO in ICU. Recommendations of the Spanish Society of Critical Care Medicine and Coronary Units. Med Intensiva 2019;43(2):108-120.

Gerth HU, Pohlen M, Tholking G, et al. Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: results from a case-control study. PLoS ONE 2017;12(4):e0175529.

Kantola T, Koivusalo AM, Hockerstedt K, et al. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients. Transpl Int 2008;21:857-66.

Klammt S, Mitzner SR, Stange J, et al. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver Transpl 2008;14:1333-9.

Kramer L, Kodras K. Detoxification as a treatment goal in hepatic failure. Liver Int 2011;31:1-4.

Larsen FS, Schmidt LE, Bernsmeier C. High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial. J Hepatol 2016; 64(1):69-78.

Mathurin P. Is alcoholic hepatitis an indication for transplantation? Current management and outcomes. Liver Transpl 2005;11:21-4.

Mehta RL, McDonald B, Gabbai FB, et al. Collaborative Group for Treatment of ARF in the ICU. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001;60(3):1154-63.

Papazian L, Aubron C, Brochard L et al. Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care 2019;9:69.

Rifai K, Ernst T, Kretschmer U, et al. The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif 2005;23:298-302.

Ronco C, Ratanarat R, Bellomo R, et al. Multiple organ support therapy for the critically ill patient in intensive care. Journal of Organ Dysfunction 2005;1:57-68.

Ronco C, Ricci Z, Husain-Syed F. From Multiple Organ Support Therapy to Extracorporeal Organ Support in Critically Ill Patients. Blood Purif 2019;48(2):99-105.

Seczyńska B, Królikowski W, Nowak I, et al. Continuous renal replacement therapy during extracorporeal membrane oxygenation in patients treated in medical intensive care unit: technical considerations. Ther Apher Dial 2014;18(6):523-34.

Sen S, Davies NA, Mookerjee RP, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 2004;10:1109-19.

Stange J. Extracorporeal liver support. Organogenesis 2011;7:1,64-73.

Stange J, Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver. Int J Artif Organs 1996;19:677- 91.

Steiner C, Mitzner S. Experiences with MARS® liver support therapy in liver failure: Analysis of 176 patients of the International MARS® Registry. Liver 2002; 22:20-5.

Steiner C, Sen S, Stange J, et al. Binding of bilirubin and bromosulphthalein to albumin: Implications for understanding the pathophysiology of liver failure and its management. Liver Transpl 2004;10:1531-8.

Şentürk E, Özcan PE, Orhun G, ve ark. Karaciğer Yetersizliğinde Uygulanan Ekstrakorporeal Destek Sistemlerinin Etkileri Turk J Anesth Reanim 2012;40(5): 269-73.

Tillmann BW, Klingel ML, Lansavichene AE et al. Extracorporeal membrane oxygenation (ECMO) as a treatment strategy for severe acute respiratory distress syndrome (ARDS) in the low tidal volume era: a systematic review. J Crit Care 2017;41:64-71.

Uchino S, Bellomo R, Ronco C. Intermittent vs. continuous renal replacement in the ICU: impact on sodium, potassium, and bicarbonate concentrations. Intensive Care Med 2001;27:1037-43.

Vinsonneau C, Camus C, Combes A, et al.; Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006;368(9533):379-85.

Yancy CW, Jessup M, Bozkurt B, et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 2017;136:137-61

Boyle A, Ascheim D, Russo M, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant 2011; 30:402-7.

Fernández-Mondéjar E, Fuset-Cabanes MP, Grau-Carmona T, et al. The use of ECMO in ICU. Recommendations of the Spanish Society of Critical Care Medicine and Coronary Units. Med Intensiva 2019;43(2):108-120.

Gerth HU, Pohlen M, Tholking G, et al. Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: results from a case-control study. PLoS ONE 2017;12(4):e0175529.

Kantola T, Koivusalo AM, Hockerstedt K, et al. The effect of molecular adsorbent recirculating system treatment on survival, native liver recovery, and need for liver transplantation in acute liver failure patients. Transpl Int 2008;21:857-66.

Klammt S, Mitzner SR, Stange J, et al. Improvement of impaired albumin binding capacity in acute-on-chronic liver failure by albumin dialysis. Liver Transpl 2008;14:1333-9.

Kramer L, Kodras K. Detoxification as a treatment goal in hepatic failure. Liver Int 2011;31:1-4.

Larsen FS, Schmidt LE, Bernsmeier C. High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial. J Hepatol 2016; 64(1):69-78.

Mathurin P. Is alcoholic hepatitis an indication for transplantation? Current management and outcomes. Liver Transpl 2005;11:21-4.

Mehta RL, McDonald B, Gabbai FB, et al. Collaborative Group for Treatment of ARF in the ICU. A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001;60(3):1154-63.

Papazian L, Aubron C, Brochard L et al. Formal guidelines: management of acute respiratory distress syndrome. Ann Intensive Care 2019;9:69.

Rifai K, Ernst T, Kretschmer U, et al. The Prometheus device for extracorporeal support of combined liver and renal failure. Blood Purif 2005;23:298-302.

Ronco C, Ratanarat R, Bellomo R, et al. Multiple organ support therapy for the critically ill patient in intensive care. Journal of Organ Dysfunction 2005;1:57-68.

Ronco C, Ricci Z, Husain-Syed F. From Multiple Organ Support Therapy to Extracorporeal Organ Support in Critically Ill Patients. Blood Purif 2019;48(2):99-105.

Seczyńska B, Królikowski W, Nowak I, et al. Continuous renal replacement therapy during extracorporeal membrane oxygenation in patients treated in medical intensive care unit: technical considerations. Ther Apher Dial 2014;18(6):523-34.

Sen S, Davies NA, Mookerjee RP, et al. Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study. Liver Transpl 2004;10:1109-19.

Stange J. Extracorporeal liver support. Organogenesis 2011;7:1,64-73.

Stange J, Mitzner S. A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver. Int J Artif Organs 1996;19:677- 91.

Steiner C, Mitzner S. Experiences with MARS® liver support therapy in liver failure: Analysis of 176 patients of the International MARS® Registry. Liver 2002; 22:20-5.

Steiner C, Sen S, Stange J, et al. Binding of bilirubin and bromosulphthalein to albumin: Implications for understanding the pathophysiology of liver failure and its management. Liver Transpl 2004;10:1531-8.

Şentürk E, Özcan PE, Orhun G, ve ark. Karaciğer Yetersizliğinde Uygulanan Ekstrakorporeal Destek Sistemlerinin Etkileri Turk J Anesth Reanim 2012;40(5): 269-73.

Tillmann BW, Klingel ML, Lansavichene AE et al. Extracorporeal membrane oxygenation (ECMO) as a treatment strategy for severe acute respiratory distress syndrome (ARDS) in the low tidal volume era: a systematic review. J Crit Care 2017;41:64-71.

Uchino S, Bellomo R, Ronco C. Intermittent vs. continuous renal replacement in the ICU: impact on sodium, potassium, and bicarbonate concentrations. Intensive Care Med 2001;27:1037-43.

Vinsonneau C, Camus C, Combes A, et al.; Hemodiafe Study Group. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet. 2006;368(9533):379-85.

Yancy CW, Jessup M, Bozkurt B, et al. ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 2017;136:137-61